Latest News on Invagen Pharmaceuticals Inc
Showing of 0 - 10 from 1 results
Invagen Pharmaceuticals Inc - Total results - 1
Nov 13, 2018
Cipla's subsidiary InvaGen Pharmaceuticals Inc to acquire US-based Avenue Therapeutics for $215 mnAvenue Therapeutics is focused on the development and commercialisation of intravenous (IV) Tramadol, a painkiller.